Promising PET scanner tool developed for rare medullary thyroid cancer

A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine.

Joint Replacement Outcomes a Bit Better With Patient Reports Post-Surgery

Patient-reported outcome measures (PROMs) following knee and hip replacement procedures showed “a small improvement” over usual post-surgery care when patients were asked to submit them

September 2, 2023

Unpacking Medicare Advantage Terminations and How Plans Can Navigate Them

David J. Sand, MD, MBA Chief Medical Officer at ZeOmega The U.S. healthcare system has been undergoing its own stress test. Stakeholders are currently experiencing a variety

November 26, 2024

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health,

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.